Long-term humoral response following Delta and Omicron BA.1 co-infection.
Carla SaadeBruno PozzettoMelyssa Yaugel NovoaGuy OriolLaurence JossetBruno LinaStephane PaulAntonin BalSophie Touillet-AssantPublished in: NPJ vaccines (2023)
This study reports the 6-month humoral immune response in vaccinated patients concomitantly infected with Delta and Omicron BA.1 variants of SARS-CoV-2. Interestingly, the simultaneous exposure to the Delta and BA.1 S proteins does not confer an additional immune advantage compared to exposure to the BA.1 S protein alone.
Keyphrases
- immune response
- sars cov
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- dendritic cells
- prognostic factors
- peritoneal dialysis
- toll like receptor
- respiratory syndrome coronavirus
- inflammatory response
- protein protein
- binding protein
- emergency department
- gene expression
- adverse drug